Scandion Oncology
Overcoming cancer drug resistance
Navbar
About us
Executive Management
Board of Directors
Clinical Advisory Board
Research & Development
Pipeline
Clinical Development
Science
Cancer drug resistance
Technology Platform
SCO-101
Press releases
Investors & Media
Share information
Financial Reports
Annual reports
Interim reports
Presentations
Media
Image library
Video library
Analyst Coverage
Prospectuses
Rights Issue 2022
Rights Issue 2020
Rights Issue 2019
Subscription Warrant (SCOL TO 1)
IPO 2018
Corporate governance
Events
General meetings
Financial calendar
Contact
Career
Business development
Skip to content
Investors
Year-end reports